Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study-Reference-Cited by-同舟云学术

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study

Published:2015-02-12 Issue:4 Volume:70 Page:311-319
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Buhl R.,Gessner C.,Schuermann W.,Foerster K.,Sieder C.,Hiltl S.,Korn S.

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2014. http://www.goldcopd.com/

2. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study;Bateman;Eur Respir J,2013

3. Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD;Donohue;Respir Med,2013

4. Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs;Toy;Respir Med,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data;European Journal of Clinical Pharmacology;2023-07-29

2. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis;Advances in Therapy;2022-07-20

3. Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD;Therapeutic Advances in Respiratory Disease;2022-01

4. Safety and Efficacy of Formoterol/Tiotropium Bromide and Formoterol/Glycopyrronium in Patients of Grade-2 COPD;SSRN Electronic Journal;2022

5. What conservative interventions can improve the long-term quality of life, depression, and anxiety of individuals with stable COPD? A systematic review and meta-analysis;Quality of Life Research;2021-08-12